Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B YH Huang, LT Hsiao, YC Hong, TJ Chiou, YB Yu, JP Gau, CY Liu, ... Journal of clinical oncology 31 (22), 2765-2772, 2013 | 365 | 2013 |
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells WT Tai, CW Shiau, HL Chen, CY Liu, CS Lin, AL Cheng, PJ Chen, ... Cell death & disease 4 (2), e485, 2013 | 210 | 2013 |
CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells KF Chen, CY Liu, YC Lin, HC Yu, TH Liu, DR Hou, PJ Chen, AL Cheng Oncogene 29 (47), 6257-6266, 2010 | 194 | 2010 |
UGT1A1* 28 polymorphism predicts irinotecan‐induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma CY Liu, PM Chen, TJ Chiou, JH Liu, JK Lin, TC Lin, WS Chen, JK Jiang, ... Cancer 112 (9), 1932-1940, 2008 | 155 | 2008 |
Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1–Mediated Inhibition of STAT3 WT Tai, AL Cheng, CW Shiau, CY Liu, CH Ko, MW Lin, PJ Chen, KF Chen Molecular cancer therapeutics 11 (2), 452-463, 2012 | 134 | 2012 |
CIP2A is a target of bortezomib in human triple negative breast cancer cells LM Tseng, CY Liu, KC Chang, PY Chu, CW Shiau, KF Chen Breast Cancer Research 14 (2), 1, 2012 | 133 | 2012 |
Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A–dependent phospho-Akt inactivation in estrogen receptor–negative human breast cancer cells CY Liu, MH Hung, DS Wang, PY Chu, JC Su, TH Teng, CT Huang, ... Breast Cancer Research 16 (5), 1, 2014 | 123 | 2014 |
Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence CY Liu, CC Yen, WM Chen, TH Chen, PCH Chen, HTH Wu, CY Shiau, ... Annals of surgical oncology 17 (8), 2102-2111, 2010 | 120 | 2010 |
Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia C Chen, C Zhang, L Cheng, JL Reilly, JR Bishop, JA Sweeney, HY Chen, ... Bipolar disorders 16 (8), 790-799, 2014 | 109 | 2014 |
A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system YB Yu, JP Gau, CY Liu, MH Yang, SC Chiang, HC Hsu, YC Hong, ... Thrombosis and haemostasis 108 (2), 225-235, 2012 | 106 | 2012 |
Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis CH Wang, CT Yu, HC Lin, CY Liu, HP Kuo Tubercle and Lung Disease 79 (4), 235-242, 1999 | 106 | 1999 |
Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation HC Yu, CS Lin, WT Tai, CY Liu, CW Shiau, KF Chen Journal of Biological Chemistry 288 (25), 18249-18259, 2013 | 96 | 2013 |
Accuracy of CNV detection from GWAS data D Zhang, Y Qian, N Akula, N Alliey-Rodriguez, J Tang, ES Gershon, C Liu PLoS One 6 (1), e14511, 2011 | 92 | 2011 |
Stromal Cell–Derived Factor 1 as a Biomarker of Heart Failure and Mortality Risk S Subramanian, C Liu, A Aviv, JE Ho, P Courchesne, P Muntendam, ... Arteriosclerosis, thrombosis, and vascular biology 34 (9), 2100-2105, 2014 | 88 | 2014 |
SNP Cutter: a comprehensive tool for SNP PCR–RFLP assay design R Zhang, Z Zhu, H Zhu, T Nguyen, F Yao, K Xia, D Liang, C Liu Nucleic acids research 33 (suppl 2), W489-W492, 2005 | 88 | 2005 |
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity KF Chen, WT Tai, CY Hsu, JW Huang, CY Liu, PJ Chen, IK Kim, ... European journal of medicinal chemistry 55, 220-227, 2012 | 87 | 2012 |
Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes EN Smith, DL Koller, C Panganiban, S Szelinger, P Zhang, JA Badner, ... PLoS Genet 7 (6), e1002134, 2011 | 87 | 2011 |
Quadric surface extraction using genetic algorithms YH Chen, CY Liu Computer-Aided Design 31 (2), 101-110, 1999 | 87 | 1999 |
A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation X Hou, JE Liu, W Liu, CY Liu, ZY Liu, ZY Sun Oncogene 30 (26), 2933-2942, 2011 | 86 | 2011 |
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma MH Chen, KC Chiang, CT Cheng, SC Huang, YY Chen, TW Chen, ... Oncotarget 5 (9), 2372-2389, 2014 | 82 | 2014 |